The Other Side of Possible
Agios Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel investigational medicines to treat cancer and rare genetic metabolic disorders through scientific leadership.
As a leader in the field of cellular metabolism and precision medicine, Agios has communication objectives that focus on growing relationships with media and investors to educate the public and patient community about the depth of Agios’ science and research. We work with Agios on an integrated corporate communications strategy spanning public relations, media relations, investor relations and creative content development.
To solidify Agios’ corporate narrative and elevate engagement, we launched Agios’ new website to lay the groundwork for the company’s evolution to a commercial-stage
biopharmaceutical company and showcase their dedication to their work and the patient. The new corporate narrative and branding successfully establish Agios as a leader in oncology and reinforce their commitment to developing novel drugs for patients.
To enhance the visibility of their leadership team, we secured various media opportunities with top-tier outlets as well as a speaking opportunity for Agios to participate alongside other leaders in the healthcare space. By defining corporate voices, the company aims to build relationships with key audiences while educating media, investors and patients about Agios’ corporate strategy and their novel approach to addressing key therapeutic areas.